Vicore Pharma Holding AB (publ)

DB:6Y4 Stock Report

Market Cap: €156.6m

Vicore Pharma Holding Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Ahmed Mousa

Chief executive officer

SEK 6.3m

Total compensation

CEO salary percentage23.5%
CEO tenure2.2yrs
CEO ownershipn/a
Management average tenure1.2yrs
Board average tenure1.8yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Ahmed Mousa's remuneration changed compared to Vicore Pharma Holding's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2024n/an/a

-SEK 169m

Sep 30 2024n/an/a

-SEK 196m

Jun 30 2024n/an/a

-SEK 200m

Mar 31 2024n/an/a

-SEK 213m

Dec 31 2023SEK 6mSEK 1m

-SEK 311m

Compensation vs Market: Ahmed's total compensation ($USD625.86K) is about average for companies of similar size in the German market ($USD815.06K).

Compensation vs Earnings: Insufficient data to compare Ahmed's compensation with company performance.


CEO

Ahmed Mousa (39 yo)

2.2yrs

Tenure

SEK 6,339,074

Compensation

Mr. Ahmed S. Mousa, J. D., serves as Chief Executive Officer at Vicore Pharma Holding AB (publ) since 2023. He served as General Counsel at Pieris Pharmaceuticals, Inc., since October 2018 until September...


Leadership Team

NamePositionTenureCompensationOwnership
Ahmed Mousa
Chief Executive Officer2.2yrsSEK 6.34mno data
Hans Jeppsson
Chief Financial Officer7.8yrsno data0.0021%
€ 3.3k
Mikael Nygård
Chief Operating Officer1.2yrsno data0.0017%
€ 2.7k
Johan Raud
Chief Scientific Officer7.2yrsno data0.10%
€ 159.6k
Bertil Lindmark
Chief Medical Officer1.3yrsno datano data
Jimmie Hofman
Vice President of Business Development1.2yrsno datano data
Helen Barker
VP & Head of CMC1.2yrsno datano data
Lene Eskildsen
Head of Quality Assuranceless than a yearno datano data
Anne-Katrine Cohrt
Head of Clinical Operationsless than a yearno datano data
Jonathan Langley
Head of Global Medical Affairsless than a yearno datano data

1.2yrs

Average Tenure

Experienced Management: 6Y4's management team is not considered experienced ( 1.2 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Jacob Gunterberg
Independent Directorno dataSEK 886.00k0.0027%
€ 4.3k
Michael Buschle
Director1.8yrsSEK 405.00kno data
Ann Barbier
Independent Directorless than a yearno datano data
Yasir Al-Wakeel
Independent Directorless than a yearno datano data
Hans J. G. C. Schikan
Independent Chairman6.6yrsSEK 450.00k0.0017%
€ 2.7k
Elisabeth Bjork
Director1.8yrsSEK 405.00kno data
Heidi Hunter
Independent Director4.8yrsSEK 519.00k0.0021%
€ 3.3k

1.8yrs

Average Tenure

63yo

Average Age

Experienced Board: 6Y4's board of directors are not considered experienced ( 1.8 years average tenure), which suggests a new board.


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/03/14 02:39
End of Day Share Price 2025/03/14 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Vicore Pharma Holding AB (publ) is covered by 5 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Hanseung YooBryan Garnier & Co
Oscar Haffen LammBryan Garnier & Co
Patrik LingDNB Markets